Elissa S. Cote insider trades
Open-market stock purchases and sales by Elissa S. Cote, Chief Corp Development Officer at Vistagen Therapeutics, Inc, from SEC Form 4 filings since Jun 23, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 7, 2026 | VTGN Vistagen Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- VTGN Vistagen Therapeutics, Inc: other filings, last Apr 7, 2026